NCT06771219View on ClinicalTrials.gov

SLV-154 Treatment of Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 14, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

April 30, 2027

Conditions
Squamous Cell Cancer of Head and Neck (SCCHN)NSCLCSCLCCervical Cancer MetastaticBreast Cancer MetastaticEndometrial CancerOvarian CancerUrothelial CancerSarcomaThyroid Cancer
Interventions
DRUG

SLV-154

SLV-154

Trial Locations (7)

63110

RECRUITING

Washington University, St Louis

77030

RECRUITING

MD Anderson Cancer Center, Houston

RECRUITING

Oncology Consultants, Houston

78229

RECRUITING

Mays Cancer Center; University of Texas Health San Antonio, San Antonio

92663

RECRUITING

Hoag Memorial Hospital Presbyterian, Newport Beach

98109

RECRUITING

University of Washington / Fred Hutchinson Cancer Center, Seattle

98405

RECRUITING

Northwest Medical Specialties, PLLC, Tacoma

All Listed Sponsors
lead

Solve Therapeutics

INDUSTRY